+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain

Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain

Cochrane Database of Systematic Reviews 2006(4): Cd003348

Patients may control postoperative pain by self-administration of intravenous opioids using devices designed for this purpose (patient controlled analgesia or PCA). A 1992 meta-analysis by Ballantyne found a strong patient preference for PCA over conventional analgesia but disclosed no differences in analgesic consumption or length of postoperative hospital stay. Although Ballantyne's meta-analysis found that PCA did have a small but statistically significant benefit upon pain intensity, Walder's review in 2001 did not find a significant differences in pain intensity and pain relief between PCA and conventionally treated groups. To evaluate the efficacy of PCA versus conventional analgesia (such as a nurse administering an analgesic upon a patient's request) for postoperative pain control. Randomized controlled trials (RCTs) were identified from the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2004, Issue 3), MEDLINE (1966 to 2004), and EMBASE (1994 to 2004). Additional reports were identified from the reference lists of retrieved papers. RCTs of PCA versus conventional analgesia that employed pain intensity as a primary or secondary outcome were selected. These trials included RCTs that compared PCA without a continuous background infusion versus conventional parenteral analgesic regimens. Studies that explicitly stated they involved patients with chronic pain were excluded. Trials were scored using the Oxford Quality Scale. Meta-analyses were performed of outcomes that included analgesic efficacy assessed by a Visual Analog Scale (VAS), analgesic consumption, patient satisfaction, length of stay and adverse effects. A sufficient number of the retrieved trials reported these parameters to permit meta-analyses. Fifty-five studies with 2023 patients receiving PCA and 1838 patients assigned to a control group met inclusion criteria. PCA provided better pain control and greater patient satisfaction than conventional parenteral 'as-needed' analgesia. Patients using PCA consumed higher amounts of opioids than the controls and had a higher incidence of pruritus (itching) but had a similar incidence of other adverse effects. There was no difference in the length of hospital stay. This review provides evidence that PCA is an efficacious alternative to conventional systemic analgesia for postoperative pain control.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 049871955

Download citation: RISBibTeXText

PMID: 17054167

DOI: 10.1002/14651858.cd003348.pub2

Related references

Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database of Systematic Reviews 2015(6): Cd003348, 2015

Pain therapy after thoracotomies--systemic patient-controlled analgesia (PCA) with opioid versus intercostal block and interpleural analgesia. Anaesthesiologie und Reanimation 22(6): 159-163, 1997

Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database of Systematic Reviews 2005(1): Cd004088, 2005

Oral immediate and prolonged release oxycodone for safe and effective patient controlled analgesia after surgery Can opioid for acute postoperative pain be improved by adding a peripheral opioid antagonist?. Scandinavian Journal of Pain 7(1): 25-27, 2015

Pain therapy after thoracoscopic interventions. Do regional analgesia techniques (intercostal block or interpleural analgesia) have advantages over intravenous patient-controlled opioid analgesia (PCA)?. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 70(6): 682-689, 1999

Influence of Opioid Epidural Analgesia + PCEA Versus Intravenous Opioid Analgesia + PCA on Weaning Time and Postoperative Pulmonary Function. Anesthesiology Abstracts of Scientific Papers Annual Meeting (2001): Abstract No A-854, 2002

Postoperative pain therapy in minimally invasive direct coronary arterial bypass surgery. I.v. opioid patient-controlled analgesia versus intercostal block. Der Anaesthesist 51(3): 175-179, 2002

A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain. Pain Management 6(1): 19-24, 2016

A statistical model for pain in patient-controlled analgesia and conventional intramuscular opioid regimens. Anesthesia and Analgesia 67(5): 457-461, 1988

Differential indications of non-opioid drugs for postoperative analgesia II. Quantification of the analgesic effect of a combination of metamizol plus diclofenac via patient-controlled analgesia. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 31(4): 216-221, 1996

Postoperative pain scores and opioid consumption in opioid-dependent patients with cancer after intraoperative remifentanil analgesia: A prospective case-controlled study. Journal of Opioid Management 13(4): 221-228, 2018

Efficacy of patient-controlled versus conventional analgesia for postoperative pain. Clinical Pharmacy 4(1): 48-52, 1985

Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiologica Scandinavica 45(7): 795-804, 2001

Differences in postoperative opioid consumption in patients prescribed patient-controlled analgesia versus intramuscular injection. Pain Management Nursing 6(4): 137-144, 2005

Influence of patient-controlled epidural analgesia versus patient-controlled intravenous analgesia on postoperative pain control and recovery after gastrectomy for gastric cancer: a prospective randomized trial. Gastric Cancer 16(2): 193-200, 2013